Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective

Vaccine

Volumn 29, Issue 6, 2011, Pages 1135-1138

  Abelin, Atika ^a   Colegate, Tony ^a   Gardner, Stephen ^b   Hehme, Norbert ^a   Palache, Abraham ^a  

^a International Federation of Pharmaceutical Manufacturers and Associations   (Switzerland)

^b Influenza Working Group Chairman   (Belgium)

Author keywords

H1N1 vaccine; Pandemic influenza

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; DEVELOPING COUNTRY; DRUG APPROVAL; DRUG INDUSTRY; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE POLICY; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INTERPERSONAL COMMUNICATION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

DRUG APPROVAL; DRUG INDUSTRY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERNATIONAL COOPERATION; PANDEMICS;

EID: 78751567830     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.042     Document Type: Review

References (21)

1. WHO. Statement from WHO global advisory committee on vaccine safety about the safety profile of pandemic influenza A(H1N1) 2009 vaccines. 18 December 2009. http://www.who.int/csr/resources/publications/swineflu/cp164_2009_1612_gacvs_h1n1_vaccine_safety.pdf.
2. European Medicines Agency. 15th pandemic pharmacovigilance update. 8 April 2010. http://www.ema.europa.eu/pdfs/influenza/21323810en.pdf.
3. US Centers for Disease Control and Prevention. Summary of 2009 monovalent H1N1 influenza vaccine data - vaccine adverse event reporting system. Data through March 26; 2010. http://vaers.hhs.gov/resources/2010H1N1Summary_Apr01.pdf.
4. Fifty-eighth World Health Assembly resolution WHA58.5. Strengthening pandemic-influenza preparedness and response. http://apps.who.int/gb/ebwha/pdf_files/WHA58/WHA58_5-en.pdf.
5. European Parliament resolution on the strategy against an influenza pandemic. 26 October 2005. http://www.europarl.europa.eu/sides/getDoc.do?type=TA&reference=P6-TA-2005-0406&language=EN.
6. Oliver Wyman. Influenza vaccine supply and demand. March 2009. http://www.oliverwyman.com/ow/pdf_files/Influenza_Vaccine_Supply__Demand_Study_-_Summary_of_Findings_.pdf.
7. Arepanrix Summary of Product Characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001201/WC500089737.pdf.
8. Celvapan Summary of Product Characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000982/WC500022670.pdf.
9. Focetria Summary of Product Characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000710/WC500023749.pdf.
10. Humenza Summary of Product Characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001202/WC500094348.pdf.
11. Pandemrix Summary of Product Characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000832/WC500038121.pdf.
12. Ph. Eur. 7th ed. 2011. European pharmacopoeia 7.0, 08 vaccines, vaccines for human use, European pharmacopoeia Monograph 01/2008:0869, influenza vaccine (surface antigen, inactivated). p. 789-91.
13. Ph. Eur. 7th ed. 2011. European pharmacopoeia 7.0, 08 vaccines, vaccines for human use, European pharmacopoeia monograph 04/2009:2149, influenza vaccine (surface antigen, inactivated, prepared in cell cultures). p. 791-93.
14. WHO. Update on A(H1N1) pandemic and seasonal vaccine availability. 7 July 2009. http://www.who.int/immunization/sage/3.MPK-SAGE_7_July.pdf.
15. WHO Wkly Epidemiol Rec 2009, 30(84):301-308. http://www.who.int/wer/2009/wer8430.pdf.
16. Ehrlich H, Mvller M, Oh H, Tambyah P, Joukhadar C, Montomoli E., et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008, 358:2573-2584. http://content.nejm.org/cgi/reprint/358/24/2573.pdf.
17. Rhorer J., Ambrose C., Dickinson S., Hamilton H., Oleka N., Malinoski F., et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine 2009, 27:1101-1110.
18. WHO. Pandemic (H1N1) 2009 vaccine deployment update - 1 March 2010. http://www.who.int/csr/disease/swineflu/vaccines/h1n1_vaccine_deployment_update20100301.pdf.
19. WHO Wkly Epidemiol Rec 2009, 49(84):505-508. http://www.who.int/wer/2009/wer8449.pdf.
20. WHO. Transcript of WHO virtual press conference of 6 August 2009. http://www.who.int/mediacentre/pandemic_h1n1_presstranscript_2009_08_06.pdf.
21. US Centers for Disease Control and Prevention MMWR 2010, 59(April (12)):357-362. http://www.cdc.gov/mmwr/pdf/wk/mm5912.pdf.